反応式
F[C:2]1[CH:7]=[CH:6][C:5]([N+:8]([O-:10])=[O:9])=[C:4]([O:11][CH2:12][CH3:13])[CH:3]=1.[C:14]([N:17]1[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]1)(=[O:16])[CH3:15].C(=O)([O-])[O-].[K+].[K+]>CN(C)C=O>[CH2:12]([O:11][C:4]1[CH:3]=[C:2]([N:20]2[CH2:21][CH2:22][N:17]([C:14](=[O:16])[CH3:15])[CH2:18][CH2:19]2)[CH:7]=[CH:6][C:5]=1[N+:8]([O-:10])=[O:9])[CH3:13]参加物
5
実験手順
The compound obtained in Step 1 above (300 mg), N-acetylpiperazine (300 mg), and potassium carbonate (500 mg) were dissolved in dimethylformamide (3 mL) and reacted at 80° C. overnight. The dimethylformamide of the reaction mixture was removed under reduced pressure, and added with water to form a solid. The solid was filtered to obtain a target compound as a yellow solid.
後処理
- customreacted at 80° C. overnight
- customThe dimethylformamide of the reaction mixture was removed under reduced pressure
- additionadded with water
- customto form a solid
- filtrationThe solid was filtered
出典と根拠
- ORDレコード
- ord-2c8e1a83285440b6b1edfc06111e3ca8
- 出典データセット
- uspto-grants-2015_12
- 特許番号
- US09199944B2
関連ノート
読み込み中…